Outsourcing

Mar 15, 2018
BioPharm International
Successful outsourcing relationships for early phase analytics in drug development are driven by partnership.
Mar 15, 2018
BioPharm International
A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics.
Mar 15, 2018
BioPharm International
Contract testing organizations can provide bio/pharma companies with a cost-effective way to adapt to new technologies and regulations.
Mar 07, 2018
By BioPharm International Editors
Grand River Aseptic Manufacturing announces first planned investment in capacity expansion.
Mar 02, 2018
By BioPharm International Editors
Catalent completes $4.6 million expansion at Singapore clinical supply facility and marks 20 years in the region.
Mar 01, 2018
BioPharm International
Development and adoption of new technologies create challenges that may take years to resolve.
Feb 23, 2018
By BioPharm International Editors
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
Feb 22, 2018
By BioPharm International Editors
Avid Bioservices will provide commercial manufacture of an enzyme replacement therapy by Roivant Sciences' Enzyvant subsidiary.
Feb 22, 2018
By BioPharm International Editors
The company aims to add the additional analytical services in the European Union throughout 2018.
Feb 13, 2018
By BioPharm International Editors
A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.
native1_300x100
lorem ipsum